Wilmot Cancer Institute
- Philanthropic support has seeded several promising pilot grants that have potential to transform treatment options for cancer patients; many of these grants are eligible to apply for additional funding through foundations and federal agencies, which further amplifies the impact our donors have.
- Interventional Clinical Trials at Wilmot continued to grow, particularly for prevention studies including screenings and smoking cessation tools.
- Annual funds supported Wilmot’s recent recruitment of new faculty with a bold vision for the future, including Jamie Flerlage, MD, the new chief and academic director of the Division of Pediatric Hematology/Oncology and assistant director of clinical research at Wilmot.
Bullet points highlight impact made in 2023-24
